These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24064986)

  • 1. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
    Alipour A; Haghdoost AA; Sajadi L; Zolala F
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
    Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India.
    Solomon SS; Srikrishnan AK; Celentano DD; Johnson SC; Vasudevan CK; Murugavel KG; Anand S; Kumar MS; Solomon S; Mehta SH
    BMC Public Health; 2011 Jan; 11():39. PubMed ID: 21235816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010.
    Sajadi L; Mirzazadeh A; Navadeh S; Osooli M; Khajehkazemi R; Gouya MM; Fahimfar N; Zamani O; Haghdoost AA
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii37-40. PubMed ID: 24191292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk behaviours and seroprevalence to HIV, HBV and HCV in patients of the AIDS information and prevention center in Valencia, Spain].
    Alfonso Gil R; Hurtado Navarro I; Espacio Casanovas A; Santos Rubio G; Tomás Dols S
    Gac Sanit; 1999; 13(1):16-21. PubMed ID: 10217673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
    Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
    AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of HIV infection among female sex workers in two cities in the Republic of Moldova: the role of injection drug use and sexual risk.
    Zohrabyan L; Johnston LG; Scutelniciuc O; Iovita A; Todirascu L; Costin T; Plesca V; Cotelnic-Harea T; Ionascu G
    AIDS Behav; 2013 Oct; 17(8):2588-96. PubMed ID: 23539186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L; Assanangkornchai S; Duo L; McNeil E; Li J
    PLoS One; 2014; 9(9):e106899. PubMed ID: 25203256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV sexual risk behaviors among injection drug users in Shanghai.
    Zhao M; Du J; Lu GH; Wang QY; Xu H; Zhu M; McCoy CB
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S43-7. PubMed ID: 16769445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy.
    El-Bassel N; Gilbert L; Terlikbayeva A; Beyrer C; Wu E; Shaw SA; Ma X; Chang M; Hunt T; Ismayilova L; Primbetova S; Rozental Y; Zhussupov B
    Int J Drug Policy; 2014 Nov; 25(6):1195-203. PubMed ID: 24556208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.